Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2009
05/13/2009CN100486576C Substituted pyridinones as modulators of P38MAP kinase
05/13/2009CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use
05/13/2009CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531564 Substituted benzoxazoles as estrogenic agents
05/12/2009US7531544 Xanthine phosphodiesterase V inhibitors
05/12/2009US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide
05/12/2009US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
05/12/2009US7531532 Pyridine derivative and pyrimidine derivative
05/12/2009US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents
05/12/2009US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis
05/12/2009US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules
05/12/2009US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine
05/12/2009US7531352 Inducible plasmid vector encoding TGF-β and use thereof
05/12/2009US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use
05/12/2009US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof
05/12/2009US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
05/12/2009US7531171 Antibodies to non-functional P2X7 receptor
05/12/2009CA2492526C Method for controlling hairballs
05/12/2009CA2454435C Medical adsorbent and process for production of the same
05/12/2009CA2402742C Method of treating or inhibiting colonic polyps
05/12/2009CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs
05/12/2009CA2377299C Mesalazine controlled release oral pharmaceutical compositions
05/12/2009CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier
05/12/2009CA2264005C Piperazino derivatives as neurokinin antagonists
05/12/2009CA2201940C Method of treating diabetes mellitus using kgf
05/07/2009WO2009059050A2 Tlr modulators and methods for using the same
05/07/2009WO2009058653A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
05/07/2009WO2009058400A1 Compositions for tissue repair/regeneration
05/07/2009WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
05/07/2009WO2009057811A2 Heterocyclic compound and pharmaceutical composition thereof
05/07/2009WO2009057796A1 Laxative agent
05/07/2009WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein
05/07/2009WO2009057165A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
05/07/2009WO2009055867A1 Treatment of metabolic disease
05/07/2009US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins
05/07/2009US20090118353 Medicinal composition
05/07/2009US20090118350 Biomarkers for Identifying Efficacy of Tegaserod in Patients with Chronic Constipation
05/07/2009US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines
05/07/2009US20090118335 Acid Secretion Inhibitor
05/07/2009US20090118330 Diurea derivatives
05/07/2009US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use
05/07/2009US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them
05/07/2009US20090118314 Tumor suppressor
05/07/2009US20090118307 Aryl Sulfonamides
05/07/2009US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses
05/07/2009US20090118298 Octahydropentalene compounds as chemokine receptor antagonists
05/07/2009US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
05/07/2009US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
05/07/2009US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
05/07/2009US20090118238 Deuterium-enriched alendronate
05/07/2009US20090118225 1-Methyl Nicotinamide and Derivatives for Treatment of Gastric Injury
05/07/2009US20090118182 Fibroblast Growth Factor-Like Polypeptides
05/07/2009US20090118179 topically administering a fibroblast growth factor; treating a tooth with a dental parenchyma loss due to dental caries, tooth attrition or injury; promoting cell proliferation and differentiation; dentistry
05/07/2009US20090118173 Treatment and prevention of inflammatory bowel diseases
05/07/2009US20090118170 Buccal, polar and non-polar spray or capsule
05/07/2009US20090118160 Heterocyclic compounds and methods of use
05/07/2009US20090117209 Andrographis paniculata extract
05/07/2009US20090117193 Compositions Comprising an Active Agent
05/07/2009US20090117146 System and method for promoting hair growth and improving hair and scalp health
05/07/2009US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS
05/07/2009US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus
05/07/2009US20090117092 Collagenolytic active enzyme containing compositions, and their use in the dental field
05/07/2009US20090117064 Stable vitamin b6 derivative
05/07/2009US20090117056 Probiotic oral dosage forms
05/07/2009US20090117037 Methods Of Treatment Using CTLA-4 Antibodies
05/07/2009DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier,
05/07/2009DE102007052870A1 Verwendung von Polyethylenglykol-Pulvern und Zusammensetzungen enthaltend diese Use of polyethylene glycol and compositions comprising these powders
05/07/2009CA2704627A1 Compositions for tissue repair/regeneration
05/07/2009CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
05/07/2009CA2703240A1 Heterocyclic compound and pharmaceutical composition thereof
05/07/2009CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
05/06/2009EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue
05/06/2009EP2054429A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
05/06/2009EP2054066A2 Methods for treatment of radiation enteritis
05/06/2009EP1537206B1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
05/06/2009EP1443961B1 Glycoprotein compositions
05/06/2009EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
05/06/2009EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide
05/06/2009EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists
05/06/2009EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/06/2009EP1173155A4 Gum pad for delivery of medication to mucosal tissues
05/06/2009EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity
05/06/2009EP1089724B1 Cyano substituted oleanolic acid derivatives as no production inhibitors
05/06/2009EP0935417B1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
05/06/2009CN101426792A Pyrazolopyrimidines as therapeutic agents
05/06/2009CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses
05/06/2009CN101426528A Methods of using antibodies against human IL-22
05/06/2009CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
05/06/2009CN101426491A GIP secretion inhibitor
05/06/2009CN101426484A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
05/06/2009CN101423811A Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
05/06/2009CN101423555A Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication
05/06/2009CN101423554A Antivariant streptococcus polypeptide and use thereof and preparation method
05/06/2009CN101423500A Substituted benzoxazoles and analogues as estrogenic agents
05/06/2009CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same
05/06/2009CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same
05/06/2009CN101422609A Use of lentinan as hepatic C virus nucleic acid vaccine immunologic adjavant
05/06/2009CN101422595A Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof
05/06/2009CN101422590A Medicine for treating toothache and preparation method thereof